Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine

Table 2 Patient demographics (n = 91)

Median Age (Range)	56 yr (26–74)
Performance Status (ECOG)
0	45
1	40
2	6
Male/Female	61/30
Primary Tumor Site
colon	69
rectum	19
appendix	2
jejunum	1
Number Prior Chemotherapy Regimens
0	4
1	40
2	37
3	10
Prior 5-fluoropyrimidine	87
Prior Irinotecan	73
Prior Radiation	19

ISSN: 1471-2407